Gufic Biosciences Stocks Soar by over 5% as it Receives Two Patents
Shital Jibhe / 06 Jun 2017
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, botanical products and medicinal chemicals. The company's segments include pharma, including formulations and bulk drugs.
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, botanical products and medicinal chemicals. The company's segments include pharma, including formulations and bulk drugs.
On Monday, Gufic Biosciences informed the bourses that it has received two patent certificates from the Intellectual Property India, the Patent Office.
It has been granted patents for two formulations viz. process for the preparation of the parental formulation of Anidulafungin, and a freeze dried parental composition of Tigecycline and process for the preparation of it.
At Rs 72.45 per share at 1123 hours IST on BSE, the Gufic Biosciences was up by 5.6%. It hit a high of Rs 73.75 and a low of Rs 71.25 during the early market hours.
Spectacular returns of more than 70% over one year’s time have been delivered by the stock. It has also outperformed BSE small-cap and BSE Healthcare over the same period.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.